Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

FTSE AIM All-Share: Arecor Therapeutics (LSE:AREC) Enters the Spotlight as Healthcare Momentum Builds

LSE:AREC is being watched for the next measurable operational, financial, project or commercial milestone.

Ankur Sharma | 11 November 2026

How Diaceutics (LSE:DXRX) Is Turning Precision Medicine Data Into Recurring Revenue on the FTSE AIM All Share Index

Diaceutics, headquartered in Belfast, sells data, analytics and consulting services that help pharmaceutical companies get targeted therapies to the right patients through diagnostic testing. It floated on AIM in March 2019, with 69,583,077 ordinary shares admitted at the time. Its Relay platform, which supports …

Divya Sood | 10 November 2026

How Weak China Demand Hit ECO Animal Health (LSE:EAH) on the FTSE AIM All Share Index

The announcement, headed as a trading update and notice of interim results, said group revenue excluding China rose 6% in the half, with South and South East Asia growing by more than 50%. China and Japan declined materially.

Divya Sood | 10 November 2026

Why EDX Medical Group (LSE:EDX) Named a New Chairman, Highlighted on the FTSE AIM All Share Index

EDX Medical is a Cambridge-based digital diagnostics company. It develops and supplies tests and services aimed at earlier disease detection, hereditary risk assessment and the selection of treatments. It operates its own laboratory and offers an employee health screening programme to employers, using proprietary …

Divya Sood | 10 November 2026

How EKF Diagnostics (LSE:EKF) Fits the FTSE AIM All Share Index After Its Interim Results

EKF is a diagnosticsBusinessreporting through two main areas. Its Point-of-Care division sells testing devices designed for use close to the patient rather than in central laboratories. Its Life Sciences division supplies materials to the laboratory and diagnostics markets and, as its 2021 trading history …

Divya Sood | 10 November 2026

Why CelLBxHealth (LSE:CLBX) Is Guiding Higher Revenue on the FTSE AIM All Share Index

CelLBxHealth develops liquid biopsy technology. Its Parsortix system captures circulating tumour cells from blood samples, and the company sells instruments, consumables and services to pharmaceutical and academic customers. Recent announcements show that laboratory use remains central: on 3 August 2026 it highlighted Parsortix-harvested cells …

Divya Sood | 10 November 2026

Why Cambridge Nutritional Sciences (LSE:CNSL) Swung to a £5.8m Loss on the FTSE AIM All Share Index

Cambridge Nutritional Sciences, known as CNSL, makes diagnostic tests for food intolerance and sells them to clinicians and partners around the world. Its product lines include FoodPrint, Food Detective and laboratory testing services under the CNSLab name.Revenuecomes from kits, laboratory work and white-label agreements, …

Divya Sood | 10 November 2026

How Cambridge Cognition (LSE:COG) Is Building an Alzheimer's Pathway, on the FTSE AIM All Share Index

Cambridge Cognition provides cognitive testing and data services, including its CANTAB digital cognitive assessment platform, used inClinical Trialsand increasingly in healthcare and consumer wellness settings. Its customers include pharmaceutical and academic organisations running studies in brain health.

Divya Sood | 10 November 2026

What Creo Medical (LSE:CREO) Interim Progress Means for the FTSE AIM All Share Index

Creo develops and sells minimally invasive surgical devices that use advanced energy, combining radiofrequency and microwave energy in a single platform. Its products are used mainly in gastrointestinal endoscopy to cut, coagulate and ablate tissue. The Speedboat device, which has been used in over …

Divya Sood | 10 November 2026

How Bioventix (LSE:BVXP) Is Balancing Steady Royalties and Alzheimer's Hopes on the FTSE AIM All Share Index

Bioventix plc, based in Farnham, develops and supplies high-affinity monoclonal antibodies generated in sheep. They are used mainly in clinical diagnostic tests. TheBusinessearns money through direct sales and royalties from customers that incorporate its antibodies into diagnostic assays, with vitamin D and troponin among …

Divya Sood | 10 November 2026
Support

Hi! How can we help you today?

Loading…